Study #2023-0331
A phase 2 study of perioperative paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology
MD Anderson Study Status
Enrolling
Treatment Agent
Paclitaxel, Dexamethasone, Diphenhydramine, Famotidine
Description
To learn about the effects of paclitaxel and gastrectomy (surgery to remove all or part of the stomach) on improving outcomes in patients with gastric cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Gastric Adenocarcinoma, Carcinomatosis
Study phase:
Phase II
Physician name:
Brian Badgwell
Department:
Surgical Oncology
For general questions about clinical trials:
1-844-252-9709
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.